Search Results for: Clinical Roundup
-
Clinic Roundup
PharmaMar SA, of Madrid, Spain, said its investigational new drug application was accepted to begin clinical testing of Zalypsis (PM00104/50), a marine antitumor agent...Interim data from an ongoing Phase I trial suggested that the drug can be given at significantly higher doses, with no significant toxicity, compared to arsenic trioxide, an inorganic form approved to treat acute promyelogenous leukemiaBioWorld Today | Wednesday, February 1, 2006 -
ICAAC Roundup
Ltd., of Tokyo, said it is initiating preclinical studies required to begin clinical testing of a fully human monoclonal antibody to the influenza A M2 protein for protection against and treatment of influenza infection...The company plans to start additional clinical studies in 2006...Tibotec Pharmaceuticals Ltd., of Cork, Ireland, said primary 24-week data from the Phase 2b trial of the protease inhibitor TMC114 in treatment-experienced patients showed that 62 percent of patients achieved aBioWorld Today | Tuesday, December 20, 2005 -
Replidyne Raises $62.5M; Health Care Remains Top Dog For VCs
And the company intends to conduct some higher-dose, shorter-course clinical trials in adults...Proceeds will be used to conduct clinical testing of the company's GP88 Biopsy Staining Kit for breast cancerBy Karen Pihl-Carey | BioWorld Today | Friday, September 9, 2005 -
Crawford: Impropriety Charge Delays Vote On Confirmation
It is thought that the ruling will not reverse the ban of high-dose ephedra...Azar served for four years as the general counsel at HHS.By Aaron Lorenzo | BioWorld Today | Monday, April 18, 2005 -
QuatRx Raises $31M In Third Round For Growing Pipeline
A third Phase I, scheduled to begin shortly, will test higher doses in a multiple-dose fashion...Its natural properties allow for large-scale manufacturing for clinical trials, and its initial safety and toxicity profiles have proved promising...and several private investors.By Aaron Lorenzo | BioWorld Today | Tuesday, December 14, 2004 -
Approved Rheumatoid Arthritis Drug Trimmed Patients' Dosage In Trials Conducted Nationwide
But the study showed that such high doses might cause adverse side effects that induce some patients to stop taking the Arava tablets...That sex bias is particularly prevalent in clinical trials testing treatments for rheumatological diseases such as RABy David N. Leff | BioWorld Today | Tuesday, January 6, 2004 -
Oral Anti-Angiogenesis Vaccine Protected Mice From Colon, Lung, Melanoma Infective Challenge
Its clinical isolates account for 34 percent of antibiotic resistance in the U.S., much higher in parts of Asia and Europe...Recipients of high-dose radiotherapy had greater memory deficits than patients not exposed to radiotherapyBy David N. Leff | BioWorld Today | Tuesday, November 12, 2002 -
Antitumor Endostatin Microbead Cell Therapy Saved Rodents From Brain Cancer In Norway And U.S.
By David N. Leff Science Editor Editor's note: Science Scan is a roundup of recently published, biotechnology-relevant research...We let our tumors grow for a week, so they're actually established before we start the cell therapy, which is more like what would happen in a clinical setting...Intractable itchiness," neurobiologist Arthur Craig told BioWorld Today, "is a serious clinical problem for several diseases of internal organs, such as the liver and the kidneyBioWorld Today | Monday, January 8, 2001 -
Wide-Ranging Neural Stem Cells, Aping Glioblastomas, Delivered Antitumor Drugs To Mice, Rats
David N. Leff Science Editor Editor's note: Science Scan is a roundup of recently published, biotechnology-relevant research...The paper concluded, "The resulting information opens the opportunity for future preclinical and clinical studies of HBsAg as an oral vaccine, with more detailed focus on communication between humoral and mucosal branches of the immune system, which may be important for the commercial development of plant-based vaccines." "A human trial of our vaccine has recently endedBioWorld Today | Monday, November 13, 2000 -
Merck Neuroscientists Crack An Alzheimer's Secret: Presenilin-1 Embodies Gamma-Secretase
By David N. Leff Science Editor Editor's note: Science Scan is a roundup of recently published biotechnology-relevant research...They develop a form of the disease with an earlier onset and shorter duration, with unusual clinical symptoms...Reasoning that nerve growth factor (NGF) is presumed to have a hand in age-related neurodegenerative disease, they raised a strain of transgenic mice expressing a high-dose, anti-NGF recombinant antibodyBioWorld Today | Monday, June 12, 2000
Category
Current Filters
- xhigh dose
Related Keywords
Categories
- x BioWorld Today (285)
- x BioWorld International (4)
- x Bio Perspectives (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.